MAPT and Alzheimer disease: Next, we also performed additional analyses for of AD-related phenotypes: Amyloid-PET (n = 313), Tau-PET imaging (n = 266), CDR (n = 2,719) and CSF Aβ42/Aβ40 ratio (n = 529, Table 2).